>peptide 1 (32 aa)
EYFNLCTENSSLSNAILFLSFHTTQKRQNDEL*
>peptide 2 (42 aa)
KNISTYVLKTLHCQMLSYFFLSIPPKKGKMMNYSSKKKQKGK*
>peptide 3 (48 aa)
MKLITLWYRCPEMILRNIESTKAFHPHKYPRNLSGELFLRKIHCLYFY*
>peptide 4 (54 aa)
MAGVDTSQNKELEIKKCRVKYLSKKKKKRKKERKKGKCRVKMGHLTVRTDTITG*
>peptide 5 (61 aa)
MQSKILIKKKKKKEKRKKEREMQSKNGTFDCENRHHYWLIETSKFHCSLHANLQSPVHSIQ*
>peptide 6 (58 aa)
MMCSSGKLILVLGFPITPCNLLNHKMRTCNCRRDCNQKGKVPLIQLFPRFRILSSEQLA
>peptide 7 (72 aa)
MQISKALFIPYSNTTSLLNSKERKMETKTINYYLQFLPLLFCLICFCCLLPKVCPIITLPVHSRIPSILSSI*
>peptide 8 (48 aa)
MILNLQLGKFMLFCIYVKQFSSKIFIASQIWKHSHGKITCKIHCKRGQ*
>peptide 9 (42 aa)
MEKLPVKYIVREVNDVQLGKIDLGFRISYNTMQSIESQDENL*
>peptide 10 (67 aa)
MPHNYSTSPLPYPINTIINLILLPVSEFSLCWEVEGGSGDASEFPRFFDKGLPFDPGFSLSKLFGNV*
>peptide 11 (40 aa)
MEVGIYSFNLFLERLIVLKILGTFMYNLCMPLDVIIMEYV*
>peptide 12 (34 aa)
MWPVRLLLERLSNRSLLSSQWRLESILLICFLRD*
>CNT0005042
AAGAATATTTCAACTTATGTACTGAAAACTCTTCATTGTCAAATGCTATCCTATTTCTTTCTTTCCATACCACCCAAAAAAGGCAAAATGATGAATTATA
GTAGCAAAAAGAAACAAAAAGGAAAATGACTATGATTCTGTAGTTATGAGGAAATGGAGGCAGGAACGAAAGAAACAGAGAACACAAGTTAGTGAATGAC
ATTGTTATACTAATGAAACGACAGTGATTTTAGTGTAGTGTAAAAATGTTTGCATTTCTTACTGCTTACAACTAAATGGCAGGTGTTGACACCTCTCAAA
ACAAAGAATTGGAGATTAAGAAATGCAGAGTAAAATACTTATCAAAAAAAAAAAAAAAAAGGAAAAAAGAAAGAAAGAAAGGGAAATGCAGAGTAAAAAT
GGGACATTTGACTGTGAGAACCGACACCATTACTGGTTGATAGAGACAAGCAAGTTTCATTGCTCCCTACATGCAAATCTCCAAAGCCCTGTTCATTCCA
TACAGTAATACCACTTCACTCCTAAACTCCAAAGAAAGAAAAATGGAGACAAAAACAATAAACTACTACCTTCAATTTCTGCCTCTCTTATTCTGCCTTA
TCTGTTTTTGTTGTCTCTTGCCAAAAGTATGCCCCATAATTACTCTACCAGTCCACTCCCGTATCCCATCAATACTATCATCAATTTAATTTTGCTGCCA
GTCTCTGAGTTTTCACTTTGTTGGGAGGTTGAAGGTGGCAGTGGTGATGCCTCAGAATTTCCACGCTTCTTTGACAAAGGGCTTCCATTTGATCCTGGGT
TTTCCTTAAGTAAGTTGTTTGGAAATGTATGAAATTGATTACTTTGTGGTATAGGTGTCCTGAGATGATTCTGAGAAACATTGAATCAACTAAGGCTTTT
CATCCTCACAAGTACCCGAGGAATCTCTCTGGAGAGCTTTTCTTAAGAAAGATCCACTGCCTCTACTTCTATTAAACTATCCAACAATGTTGTGATGTGG
CCTGTAAGACTGTTGCTGGAAAGGTTGAGCAATAGAAGCCTGTTAAGTTCCCAATGGAGGTTGGAATCTATTCTTTTAATTTGTTTCTTGAGAGATTGAT
TGTACTGAAGATATTAGGGACCTTCATGTATAACCTCTGCATGCCTTTGGATGTTATCATCATGGAGTATGTGTAATTGCCAATGATCCTGAACCTTCAG
CTAGGAAAATTCATGCTTTTCTGCATATATGTGAAGCAATTTTCATCCAAAATATTCATAGCATCCCAAATTTGGAAGCATTCTCATGGAAAAATTACCT
GTAAAATACATTGTAAGAGAGGTCAATGATGTGCAGCTCGGGAAAATTGATCTTGGTTTTAGGATTTCCTATAACACCATGCAATCTATTGAATCACAAG
ATGAGAACCTGTAATTGTAGAAGAGATTGCAACCAAAAGGGGAAAGTGCCATTGATCCAATTGTTTCCAAGATTTAGGATCTTGAGCTCTGAACAATTGG
CC
| Potential function | Interacting transcript | Gene description | Transcript biotype | lncRNA id | Alignment score (LAST) | Alignment length | Transcript region involved in interaction | Genomic orientation of interacting RNAs |
|---|---|---|---|---|---|---|---|---|
| VIT_03s0017g00510.t01 | Putative uncharacterized protein | protein coding | CNT0005042 | 94 | 172 | CDS | Trans | |
| VIT_12s0057g00860.t01 | Putative uncharacterized protein | protein coding | CNT0005042 | 311 | 397 | CDS | Trans | |
| VIT_16s0013g01700.t01 | Putative uncharacterized protein | protein coding | CNT0005042 | 211 | 512 | CDS | Trans | |
| VIT_16s0013g01730.t01 | Putative uncharacterized protein | protein coding | CNT0005042 | 323 | 588 | CDS | Trans | |
| VIT_18s0089g00660.t01 | Putative uncharacterized protein | protein coding | CNT0005042 | 91 | 112 | CDS | Trans |